151 related articles for article (PubMed ID: 27965477)
21. Association of esophageal inflammation, obesity and gastroesophageal reflux disease: from FDG PET/CT perspective.
Wu YW; Tseng PH; Lee YC; Wang SY; Chiu HM; Tu CH; Wang HP; Lin JT; Wu MS; Yang WS
PLoS One; 2014; 9(3):e92001. PubMed ID: 24642729
[TBL] [Abstract][Full Text] [Related]
22. Overweight associated with increased risk of erosive esophagitis in a non-obese Taiwanese population.
Chih PC; Yang YC; Wu JS; Chang YF; Lu FH; Chang CJ
PLoS One; 2013; 8(11):e77932. PubMed ID: 24223746
[TBL] [Abstract][Full Text] [Related]
23. ENDOSCOPIC CHANGES RELATED TO GASTROESOPHAGEAL REFLUX DISEASE: COMPARATIVE STUDY AMONG BARIATRIC SURGERY PATIENTS.
Santo MA; Quintanilha SR; Mietti CA; Kawamoto FM; Marson AG; de Cleva R
Arq Bras Cir Dig; 2015; 28 Suppl 1(Suppl 1):36-8. PubMed ID: 26537271
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and Predictors of Gastroesophageal Reflux Complications in Community Subjects.
Crews NR; Johnson ML; Schleck CD; Enders FT; Wongkeesong LM; Wang KK; Katzka DA; Iyer PG
Dig Dis Sci; 2016 Nov; 61(11):3221-3228. PubMed ID: 27510751
[TBL] [Abstract][Full Text] [Related]
25. Visceral obesity and the risk of Barrett's esophagus.
Akiyama T; Yoneda M; Maeda S; Nakajima A; Koyama S; Inamori M
Digestion; 2011; 83(3):142-5. PubMed ID: 21266807
[TBL] [Abstract][Full Text] [Related]
26. [Higher prevalence of obesity in erosive gastroesophageal reflux disease].
Biccas BN; Lemme EM; Abrahão LJ; Aguero GC; Alvariz A; Schechter RB
Arq Gastroenterol; 2009; 46(1):15-9. PubMed ID: 19466304
[TBL] [Abstract][Full Text] [Related]
27. Association of Vitamin D and Parathyroid Hormone With Barrett's Esophagus.
Rubenstein JH; McConnell D; Beer DG; Chak A; Metko V; Clines G
J Clin Gastroenterol; 2019; 53(10):711-716. PubMed ID: 30180151
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications.
Hampel H; Abraham NS; El-Serag HB
Ann Intern Med; 2005 Aug; 143(3):199-211. PubMed ID: 16061918
[TBL] [Abstract][Full Text] [Related]
29. Association between obesity and Barrett's esophagus in a Japanese population: a hospital-based, cross-sectional study.
Watari J; Hori K; Toyoshima F; Kamiya N; Yamasaki T; Okugawa T; Asano H; Li ZL; Kondo T; Ikehara H; Sakurai J; Tomita T; Oshima T; Fukui H; Miwa H
BMC Gastroenterol; 2013 Sep; 13():143. PubMed ID: 24070185
[TBL] [Abstract][Full Text] [Related]
30. Central adiposity and risk of Barrett's esophagus.
Edelstein ZR; Farrow DC; Bronner MP; Rosen SN; Vaughan TL
Gastroenterology; 2007 Aug; 133(2):403-11. PubMed ID: 17681161
[TBL] [Abstract][Full Text] [Related]
31. Characterization of acid and alkaline reflux in patients with Barrett's esophagus. G.O.S.P.E. Operative Group for the study of Esophageal Precancer.
D'Onofrio V; Bovero E; Iaquinto G
Dis Esophagus; 1997 Jan; 10(1):16-22; discussion 22-3. PubMed ID: 9079268
[TBL] [Abstract][Full Text] [Related]
32. Abdominal obesity and the risk of Barrett's esophagus.
El-Serag HB; Kvapil P; Hacken-Bitar J; Kramer JR
Am J Gastroenterol; 2005 Oct; 100(10):2151-6. PubMed ID: 16181362
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.
Csendes A; Smok G; Cerda G; Burdiles P; Mazza D; Csendes P
Dis Esophagus; 1997 Jan; 10(1):38-42. PubMed ID: 9079272
[TBL] [Abstract][Full Text] [Related]
34. Serum leptin and adiponectin levels and risk of Barrett's esophagus and intestinal metaplasia of the gastroesophageal junction.
Thompson OM; Beresford SA; Kirk EA; Bronner MP; Vaughan TL
Obesity (Silver Spring); 2010 Nov; 18(11):2204-11. PubMed ID: 20111023
[TBL] [Abstract][Full Text] [Related]
35. Serum adiponectin, resistin, leptin concentration and central adiposity parameters in Barrett's esophagus patients with and without intestinal metaplasia in comparison to healthy controls and patients with GERD.
Mokrowiecka A; Daniel P; Jasinska A; Pietruczuk M; Pawlowski M; Szczesniak P; Orszulak-Michalak D; Malecka-Panas E
Hepatogastroenterology; 2012; 59(120):2395-9. PubMed ID: 22944288
[TBL] [Abstract][Full Text] [Related]
36. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
Sharma P; Sampliner RE; Camargo E
Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303
[TBL] [Abstract][Full Text] [Related]
37. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
[TBL] [Abstract][Full Text] [Related]
38. Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study.
Nocon M; Labenz J; Jaspersen D; Meyer-Sabellek W; Stolte M; Lind T; Malfertheiner P; Willich SN
J Gastroenterol Hepatol; 2007 Nov; 22(11):1728-31. PubMed ID: 17914941
[TBL] [Abstract][Full Text] [Related]
39. Erosive esophagitis and Barrett's esophagus in Taiwan: a higher frequency than expected.
Yeh C; Hsu CT; Ho AS; Sampliner RE; Fass R
Dig Dis Sci; 1997 Apr; 42(4):702-6. PubMed ID: 9125635
[TBL] [Abstract][Full Text] [Related]
40. Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis.
Kendall BJ; Rubenstein JH; Cook MB; Vaughan TL; Anderson LA; Murray LJ; Shaheen NJ; Corley DA; Chandar AK; Li L; Greer KB; Chak A; El-Serag HB; Whiteman DC; Thrift AP
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1412-1419.e3. PubMed ID: 27264393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
